A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 1139-1147

  Kim, Kang Mi ^a   Song, Myung Ha ^a   Kim, Min Ju ^a   Daudi, Sayeema ^b   Miliotto, Anthony ^b   Old, Lloyd ^c   Odunsi, Kunle ^b   Lee, Sang Yull ^a  

^a Pusan National University School of Medicine   (South Korea)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer testis antigen; DNA methylation; Ovary cancer; Serologic analysis of recombinant cDNA expression

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CANCER TESTIS ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN G ANTIBODY; KP OVA 52 ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOGENICITY; MALE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGIC ANALYSIS OF RECOMBINANT CDNA EXPRESSION LIBRARY; SEROLOGY; SERUM; WESTERN BLOTTING;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AZACITIDINE; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE LIBRARY; HUMANS; MALE; OVARIAN NEOPLASMS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TESTICULAR NEOPLASMS;

EID: 84864982035     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1508     Document Type: Article

References (36)

1. Ovarian cancer in Australia: An overview, 2010. Australian Institute of Health and Welfare and National Breast and Ovarian Cancer Centre, Canberra, 2010.
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG and Edwards BK: SEER Cancer Statistics Review 1975-2007. National Cancer Institute: Bethesda, MD, 2011.
3. Hennessy BT, Coleman RL and Markman M: Ovarian cancer. Lancet 374: 1371-1382, 2009.
4. Jaras K and Anderson K: Autoantibodies in cancer: prognostic biomarkers and immune activation. Expert Rev Proteomics 8: 577-589, 2011.
5. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813, 1995. (Pubitemid 26014201)
6. Obata Y, Takahashi T, Sakamoto J, Tamaki H, Tominaga S, Hamajima N, Chen YT and Old LJ: SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol 46 (Suppl): S37-S42, 2000.
7. Song MH, Ha JC, Lee SM, Park YM and Lee SY: Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX. Biochem Biophys Res Commun 408: 195-201, 2011.
8. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A and Old LJ: Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95: 6919-6923, 1998. (Pubitemid 28278082)
9. Jager D, Stockert E, Scanlan MJ, Gure AO, Jager E, Knuth A, Old LJ and Chen YT: Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res 59: 6197-6204, 1999. (Pubitemid 30035643)
10. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT and Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 83: 456-464, 1999. (Pubitemid 29489858)
11. Lee SY, Williamson B, Caballero OL, Chen YT, Scanlan MJ, Ritter G, Jongeneel CV, Simpson AJ and Old LJ: Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun 4: 13, 2004.
12. Chen G, Zhang W, Cao X, Li F, Liu X and Yao L: Serological identification of immunogenic antigens in acute monocytic leukemia. Leuk Res 29: 503-509, 2005. (Pubitemid 40327238)
13. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old LJ: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918, 1997. (Pubitemid 27113936)
14. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jager D, Chen YT, Mackay A, O'Hare MJ and Old LJ: Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 1: 4, 2001.
15. Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ and Chen YT: Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 61: 2055-2061, 2001. (Pubitemid 32692027)
16. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ and Chen YT: Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188: 22-32, 2002. (Pubitemid 35398862)
17. Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ and Scanlan MJ: Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA 100: 2651-2656, 2003. (Pubitemid 36297553)
18. Simpson AJ, Caballero OL, Jungbluth A, Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5: 615-625, 2005. (Pubitemid 41081387)
19. Scanlan MJ, Simpson AJ and Old LJ: The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4: 1, 2004.
20. Caballero OL and Chen YT: Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100: 2014-2021, 2009.
21. Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K and Nelson BH: Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer 104: 73-84, 2003. (Pubitemid 36184149)
22. Luo LY, Herrera I, Soosaipillai A and Diamandis EP: Identifi-cation of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library. Br J Cancer 87: 339-343, 2002.
23. Lokshin AE, Winans M, Landsittel D, Marrangoni AM, Velikokhatnaya L, Modugno F, Nolen BM and Gorelik E: Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol Oncol 102: 244-251, 2006. (Pubitemid 44041638)
24. Jin S, Wang Y, Zhang Y, Zhang HZ, Wang SJ, Tang JQ, Chen HJ and Ge HL: Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity. Cancer Sci 99: 1670-1678, 2008.
25. Naora H, Montz FJ, Chai CY and Roden RB: Aberrant expression of homeobox gene HOXA7 is associated with mullerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc Natl Acad Sci USA 98: 15209-15214, 2001. (Pubitemid 34013993)
26. Naora H, Yang YQ, Montz FJ, Seidman JD, Kurman RJ and Roden RB: A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc Natl Acad Sci USA 98: 4060-4065, 2001. (Pubitemid 32249898)
27. The Academy of Cancer Immunology and the Ludwig Institute for Cancer Research: Cancer Immunome Database. Avaible online: http://ludwig-sun5.unil.ch/ CancerImmunomeDB, 1997.
28. Valmori D, Dutoit V, Rubio-Godoy V, Chambaz C, Lienard D, Guillaume P, Romero P, Cerottini JC and Rimoldi D: Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. Cancer Res 61: 509-512, 2001. (Pubitemid 32128608)
29. Kikuchi N, Horiuchi A, Osada R, Imai T, Wang C, Chen X and Konishi I: Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression. Cancer Sci 97: 1061-1069, 2006. (Pubitemid 44322555)
30. Lin J, Lin L, Thomas DG, Greenson JK, Giordano TJ, Robinson GS, Barve RA, Weishaar FA, Taylor JM, Orringer MB and Beer DG: Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants. Clin Cancer Res 10: 5708-5716, 2004. (Pubitemid 39180946)
31. Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M and Spagnoli GC: Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 120: 337-343, 2007. (Pubitemid 44956843)
32. Sharma P, Shen Y, Wen S, Bajorin DF, Reuter VE, Old LJ and Jungbluth AA: Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. Clin Cancer Res 12: 5442-5447, 2006. (Pubitemid 44497259)
33. Figueiredo DL, Mamede RC, Proto-Siqueira R, Neder L, Silva WA Jr and Zago MA: Expression of cancer testis antigens in head and neck squamous cell carcinomas. Head Neck 28: 614-619, 2006. (Pubitemid 44025110)
34. Shirley CR, Hayashi S, Mounsey S, Yanagimachi R and Meistrich ML: Abnormalities and reduced reproductive potential of sperm from Tnp1- and Tnp2-null double mutant mice. Biol Reprod 71: 1220-1229, 2004. (Pubitemid 39249807)
35. Park JH, Song MH, Lee CH, Lee MK, Park YM, Old L and Lee SY: Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation. Biotechnol Lett 33: 1085-1091, 2011.
36. Adair SJ and Hogan KT: Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules. Cancer Immunol Immunother 58: 589-601, 2009.